Safety and immunogenicity of candidate tuberculosis (TB) vaccine MVA85A administered by the intramuscular route and the intradermal route: a phase I randomised active controlled trial.
Phase of Trial: Phase I
Latest Information Update: 20 Sep 2016
At a glance
- Drugs MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 25 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
- 28 Dec 2009 New trial record